Xianglei Liu

450 total citations
11 papers, 151 citations indexed

About

Xianglei Liu is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Xianglei Liu has authored 11 papers receiving a total of 151 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Radiology, Nuclear Medicine and Imaging, 5 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Xianglei Liu's work include Monoclonal and Polyclonal Antibodies Research (9 papers), CAR-T cell therapy research (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Xianglei Liu is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), CAR-T cell therapy research (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Xianglei Liu collaborates with scholars based in United States, China and Canada. Xianglei Liu's co-authors include Dimiter S. Dimitrov, John W. Mellors, Aleksandra Drelich, Zehua Sun, Chien‐Te K. Tseng, Chuan Chen, Wei Li, Ralph S. Baric, David R. Martinez and Doncho V. Zhelev and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Xianglei Liu

11 papers receiving 150 citations

Peers

Xianglei Liu
Jiangfan Li China
Feiyang Luo China
Zepeng Xu China
Elaine C. Chen United States
Dan‐yun Lai China
Christian Weber France
Jalees A. Nasir Canada
Hsiu-Ting Lin Taiwan
Dejan Mesner United Kingdom
Kehu Yuan China
Jiangfan Li China
Xianglei Liu
Citations per year, relative to Xianglei Liu Xianglei Liu (= 1×) peers Jiangfan Li

Countries citing papers authored by Xianglei Liu

Since Specialization
Citations

This map shows the geographic impact of Xianglei Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianglei Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianglei Liu more than expected).

Fields of papers citing papers by Xianglei Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xianglei Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianglei Liu. The network helps show where Xianglei Liu may publish in the future.

Co-authorship network of co-authors of Xianglei Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Xianglei Liu. A scholar is included among the top collaborators of Xianglei Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xianglei Liu. Xianglei Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Xu, Wei, Luyao Song, Ying Qin, et al.. (2024). A tumor-conditional IL-15 safely synergizes with immunotherapy to enhance antitumor immune responses. Molecular Therapy. 32(12). 4482–4496. 2 indexed citations
2.
Chu, Xiaojie, Seungmin Shin, Liyong Zhang, et al.. (2024). Discovery of a novel highly specific, fully human PSCA antibody and its application as an antibody-drug conjugate in prostate cancer. mAbs. 16(1). 2387240–2387240. 1 indexed citations
3.
4.
Liu, Xianglei, et al.. (2021). Effective killing of cells expressing CD276 (B7-H3) by a bispecific T cell engager based on a new fully human antibody. Translational Oncology. 14(12). 101232–101232. 7 indexed citations
5.
Ereño‐Orbea, June, Xianglei Liu, Taylor Sicard, et al.. (2021). Structural details of monoclonal antibody m971 recognition of the membrane-proximal domain of CD22. Journal of Biological Chemistry. 297(2). 100966–100966. 13 indexed citations
6.
Xi, Zhaoyong, Xianglei Liu, Rui Lin, et al.. (2021). The reduced form of the antibody CH2 domain. Protein Science. 30(9). 1895–1903. 1 indexed citations
7.
Li, Wei, Chuan Chen, Aleksandra Drelich, et al.. (2020). Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection. Proceedings of the National Academy of Sciences. 117(47). 29832–29838. 52 indexed citations
8.
Liu, Xianglei, Aleksandra Drelich, Wei Li, et al.. (2020). Enhanced elicitation of potent neutralizing antibodies by the SARS-CoV-2 spike receptor binding domain Fc fusion protein in mice. Vaccine. 38(46). 7205–7212. 27 indexed citations
9.
Sun, Zehua, Chuan Chen, Wei Li, et al.. (2020). Potent neutralization of SARS-CoV-2 by human antibody heavy-chain variable domains isolated from a large library with a new stable scaffold. mAbs. 12(1). 1778435–1778435. 38 indexed citations
10.
Pastrana-Rı́os, Belinda, et al.. (2020). Developability Assessment of an Isolated CH2 Immunoglobulin Domain. Analytical Chemistry. 93(3). 1342–1351. 4 indexed citations
11.
Liu, Xianglei, et al.. (2020). Construction of Novel Bispecific Single-Domain Antibodies (BiSdAbs) with Potent Antiangiogenic Activities. SHILAP Revista de lepidopterología. 2(1). e64–e76. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiangfan Li Breakdown of academic impact, for papers by Feiyang Luo Breakdown of academic impact, for papers by Zepeng Xu Breakdown of academic impact, for papers by Elaine C. Chen Breakdown of academic impact, for papers by Dan‐yun Lai Breakdown of academic impact, for papers by Christian Weber Breakdown of academic impact, for papers by Jalees A. Nasir Breakdown of academic impact, for papers by Hsiu-Ting Lin Breakdown of academic impact, for papers by Dejan Mesner Breakdown of academic impact, for papers by Kehu Yuan
Rankless by CCL
2026